Abstract: Introduction: Fetal growth restriction (FGR) is a common complication of pregnancy. Placenta-derived exosomes may represent an additional pathway by which the placenta communicates with the maternal system to induce maternal vascular adaptations to pregnancy and it may be affected during FGR. The objective of this study was to quantify the concentration of total and placenta-derived exosomes in maternal and fetal circulation in small fetuses classified as FGR or small for gestational age (SGA). Methods: Prospective cohort study in singleton term gestations including 10 normally grown fetuses and 20 small fetuses, sub-classified into SGA and FGR accordingly to birth weight (BW) percentile and fetoplacental Doppler. Exosomes were isolated from maternal and fetal plasma and characterized by morphology, enrichment of exosomal proteins, and size distribution by electron microscopy, western blot, and nanoparticle tracking analysis, respectively. Total and specific placenta-derived exosomes were determined using quantum dots coupled with CD63+ve and placental-type alkaline phosphatase (PLAP)+ve antibodies, respectively. Results: Maternal concentrations of CD63+ve and PLAP+ve exosomes were similar between the groups (all p>0.05). However, there was a significant positive correlation between the ratio of placental-derived to total exosomes (PLAP+ve ratio) and BW percentile, [rho=0.77 (95% CI: 0.57 to 0.89); p=0.0001]. The contribution of placental exosomes to the total exosome concentration in maternal circulation showed a significant decrease among cases, with lower PLAP+ve ratios in FGR compared to controls and SGA cases. Likewise, the contribution of placental exosomes to the total exosome in the fetal circulation was significantly lower in cases than in controls (both p<0.001). Discussion: Quantification of placental exosomes in maternal and fetal plasma reflects fetal growth and it may be a useful indicator of placental function. Future studies with a large sample size are required to confirm these results. Fetal growth restriction (FGR) affects 7-10% of all pregnancies and is defined as the failure to 3 achieve the genetic growth potential [1, 2] . Growth restricted fetuses have a 5 to 10-fold risk 4 of dying in-utero, and a higher risk of perinatal morbidity and mortality [3] . Prenatal 5 identification of FGR has been shown to significantly reduce perinatal morbidity and 6 mortality, by 4 to 5-fold [4] . However, accurate identification of sub-optimal fetal growth in-7 utero remains to be an unsolved problem [5] . Detection of fetal smallness has proven elusive, 8 with high-quality ultrasound programs detecting not more than 50% of the cases [6] . Current conditions [16] , making them a novel mechanism of paracrine and autocrine regulation, which 27 have even been used as natural nanocarriers to deliver therapeutic agents to injured cells [17] .
28
The discovery of circulating fetal genetic material in maternal plasma has accelerated the 29 generation of new potential tools for non-invasive prenatal diagnosis. Placenta recorded at the time of delivery and the data were entered into our database. The placenta was
82
weighed using an electronic scale; the length of the surface was measured as the longest 83 diameter on the maternal side; the breadth as the longest diameter at right angles to the length.
84
Placental efficiency was defined by birth weight: placental weight ratio (BW: PW ratio).
85
Feto-placental ultrasound 86 Transabdominal ultrasound was performed at enrollment with 6-4-MHz probes (Siemens incubated with FcR blocking reagent (10 ml, 10 min at 4 C) (MACS Miltenyi Biotec),
142
followed by incubation with anti-CD63-Qdot605 or anti-PLAP-Qdot605 or IgG1-Qdot605
143
(10 ml, 1:100) for 30 min in the dark at room temperature. Samples were then diluted to 500 144 ml with PBS and analyzed using the NanoSight NS500 instrument and NTA software.
145
Samples were analyzed using fluorescence mode (i.e. camera level 9, shutter speed 11.25 ms 146 and slider gain 250). Five videos x 60 s each were captured for each sample and analyzed.
147
The specificity of the Qdot-PLAP in binding only exosomes from the placenta was measured 
Characterization of total and placental-derived exosomes

183
Exosomes were isolated from maternal and fetal plasma by differential and buoyant density 184 centrifugation (Supplemental material Figure S1 ). The distribution of particles and size number of total exosomes and placenta-derived exosomes in maternal and fetal circulation.
206
We did not find PLAP protein in exosomes isolated from non-pregnant women (Supplemental 207 material Figure S3 ). 
PLAP
-ve x 100) in cases and controls are presented in Figure 2 . The total number of 218 circulating exosomes was significantly differences (ANOVA p<0.05) across the groups 219 studied ( Figure 2A ). There were no significant differences in the maternal plasma 220 concentration of placenta-derived exosomes between cases (SGA and FGR) and controls
221
( Figure 2B ). However, the contribution of non-placental and placental exosomes was using a commercial ELISA kit (Supplemental material Figure S4A ). We did not find a 239 significant difference in the PLAP-associated exosomes across the studied groups. exosomes in fetal blood were identified (Supplemental material Table S1 ). However, when (Supplemental material Figure S4B ). We did not find a significant difference in the PLAP-265 associated exosomes across the studied groups. Placental tissue and exosomes isolated from 266 non-pregnant women were used as positive and negative control, respectively (Supplemental 267 material Figure S4C ). Finally, correlation analysis on the total, placenta-derived, and proportion of non-placenta and
282
placental origin compared to the total circulating exosomes between fetal and maternal 283 plasma was performed (Supplemental material Figure S5 ). Interestingly, a significant positive 284 correlation between the contribution of placenta-derived exosomes to the total exosomes 285 present between fetal and maternal circulation was identified ( Figure 5C ). A positive correlation between maternal and fetal circulation on the contribution of placental 296 exosomes to the total circulation exosomes was identified, suggesting a potential mechanism 297 of regulation to maintain the proportion of exosomes between these circulation.
298
In this study, we isolate exosomes using a density gradient and every fraction was analysed
299
by nanoparticle tracking analysis in fluorescence mode using quantum dots coupled with 300 CD63 or PLAP and classified by size in <35 nm, 35-150 nm, and >150 nm. As we showed in 301 the supplemental figure S2, 
414
The potential value and expression of miRNAs of placental-derived exosomes in the fetal 415 circulation may be an interesting source of knowledge to elucidate fetal response to placenta 416 dysfunction. In this study, we have shown that placental-derived exosomes can be isolated in 417 the fetal circulation, and that its concentration is influenced by placental weight and breadth.
418
In addition, there was also a strong, positive correlation with birth weight; altogether pointing 419 circulating placental-derived exosomes and their content as a valuable tool for better 420 understanding the complex maternal and fetal circulation crosstalk.
421
Comparison of these findings with previous studies
422
The concentrations and contents of exosomes are thought to depend on their cells of origin 423 and the stimuli, which trigger their production. We have also previously reported that the 
